Mobile Technology for Primary Stroke Prevention: A Proof-of-Concept Pilot Randomized Controlled Trial

被引：42

作者：

Krishnamurthi, Rita ^{[1
]}

Hale, Leigh ^{[3
]}

Barker-Collo, Suzanne ^{[4
]}

Theadom, Alice ^{[1
]}

Bhattacharjee, Rohit ^{[1
]}

George, Ann ^{[1
]}

Arroll, Bruce ^{[5
]}

Ranta, Annamarie ^{[7
,8
]}

Waters, Debra ^{[2
]}

Wilson, Denise ^{[9
,10
]}

Sandiford, Peter ^{[6
,11
]}

Gall, Seana ^{[12
]}

Parmar, Priyakumari ^{[1
]}

Bennett, Derrick ^{[13
,14
]}

Feigin, Valery ^{[1
]}

机构：

[1] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm Studies, Auckland, New Zealand

[2] Auckland Univ Technol, Taupua Waiora Ctr Maori Hlth Res, Sch Publ Hlth & Psychosocial Studies, Auckland, New Zealand

[3] Univ Otago, Sch Physiotherapy, Dept Med, Dunedin, New Zealand

[4] Univ Auckland, Sch Psychol, Auckland, New Zealand

[5] Univ Auckland, Dept Gen Practice & Healthcare, Sch Populat Hlth, Auckland, New Zealand

[6] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand

[7] Univ Otago, Dept Med, Wellington, New Zealand

[8] Wellington Hosp, Dept Neurol, Wellington, New Zealand

[9] Univ Otago, Sch Physiotherapy, Dept Med, Dunedin, New Zealand

[10] Waitemata Dist Hlth Board, Auckland, New Zealand

[11] Univ Auckland, Auckland, New Zealand

[12] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia

[13] Univ Oxford, Clin Trial Serv Unit, Nuffield Dept Populat Hlth, Oxford, England

[14] Univ Oxford, Epidemiol Studies Unit CTSU, Nuffield Dept Populat Hlth, Oxford, England

来源：

STROKE | 2019年 / 50卷 / 01期

关键词：

awareness; primary prevention; risk factors; smartphones; stroke; GLOBAL BURDEN; RISK-FACTORS; DISEASE; HEALTH; COUNTRIES;

D O I：

10.1161/STROKEAHA.118.023058

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Background and Purpose Feasibility of utilizing the Stroke Riskometer App (App) to improve stroke awareness and modify stroke risk behaviors was assessed to inform a full randomized controlled trial. Methods A parallel, open-label, 2-arm prospective, proof-of-concept pilot randomized controlled trial. Participants were randomized to usual care/control or App intervention group and assessed at baseline, 3, and 6 months. The App measures stroke risk and provides information on management of risk factors. Participants were aged >19 years with at least 2 modifiable stroke risk factors identified, no prior stroke, and owned a smartphone. Results Fifty participants (24 control, 26 App) were recruited from 148 eligible participants. Retention in the trial was 87%. Mean cardiovascular health (Life's Simple 7) improved by 0.36 (95% CI, -2.10 to 1.38) in the App group compared with 0.01 (95% CI, -1.34 to 1.32) in controls (P=0.6733). Conclusions These findings support a full randomized controlled trial to test the effectiveness of the Stroke Riskometer for primary stroke prevention. Clinical Trial Registration URL: www.anzctr.org.au. Unique Identifier: ACTRN12616000376448.

引用

页码：196 / 198

页数：3

共 50 条

[31] Weight Loss as Treatment for Gout in Patients with Concomitant Obesity: A Proof-of-Concept Randomized Controlled Trial
Zobbe, Kristian
Christensen, Robin
Nielsen, Sabrina Mai
Stamp, Lisa
Henriksen, Marius
Overgaard, Anders Fohrby
Dreyer, Lene
Knop, Filip Krag
Singh, Jasvinder
Doherty, Michael
Richette, Pascal
Astrup, Arne
Ellegaard, Karen
Bartels, Else Marie
Boesen, Mikael
Gudbergsen, Henrik Rindel
Bliddal, Henning
Kristensen, Lars Erik
[J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
[32] Proof-of-Concept Randomized Trial of the Monoclonal Antibody GSK249320 Versus Placebo in Stroke Patients
Cramer, Steven C.
Enney, Lori A.
Russell, Colleen K.
Simeoni, Monica
Thompson, Thomas R.
[J]. STROKE, 2017, 48 (03) : 692 - 698
[33] Pharmacotherapy to prevent PTSD: Results from a randomized controlled proof-of-concept trial in physically injured patients
Stein, Murray B.
Kerridge, Carol
Dimsdale, Joel E.
Hoyt, David B.
[J]. JOURNAL OF TRAUMATIC STRESS, 2007, 20 (06) : 923 - 932
[34] A Randomized, Placebo-Controlled, Proof-of-Concept Trial of Ebopiprant for the Treatment of Spontaneous Preterm Labor (PROLONG)
Mol, Ben W.
Nguyen, Anh
Fatkullin, Ildar
Herman, Hynek
Parizek, Antonin
Janku, Petr
Ho, Tuong
Biron-Shental, Tal
Humberstone, Andrew
Brethous, Michel
Gotteland, Jean-Pierre
Garner, Elizabeth
[J]. REPRODUCTIVE SCIENCES, 2021, 28 (SUPPL 1) : 135A - 135A
[35] Safety and efficacy of remote ischemic conditioning for the treatment of intracerebral hemorrhage: A proof-of-concept randomized controlled trial
Zhao, Wenbo
Jiang, Fang
Li, Sijie
Liu, Guiyou
Wu, Chuanjie
Wang, Yuang
Ren, Changhong
Zhang, Jing
Gu, Fei
Zhang, Quanzhong
Gao, Xinjing
Gao, Zongen
Song, Haiqing
Ma, Qingfeng
Ding, Yuchuan
Ji, Xunming
[J]. INTERNATIONAL JOURNAL OF STROKE, 2022, 17 (04) : 425 - 433
[36] A proof-of-concept randomized-controlled trial of omalizumab in patients with severe difficult to control nonatopic asthma
Garcia, Gilles
Magnan, Antoine
Chiron, Raphael
Girodet, Pierre-Olivier
Le Gros, Vincent
Humbert, Marc
[J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
[37] Acute effects of a motor coordination intervention on executive functions in kindergartners: a proof-of-concept randomized controlled trial
Haas, Petra
Sudeck, Gorden
Kelava, Augustin
Cattarius, Marcel
Meibohm, Marie
Schmid, Johanna
Kistoglidou, Eirini
Gawrilow, Caterina
[J]. PILOT AND FEASIBILITY STUDIES, 2022, 8 (01)
[38] Acute effects of a motor coordination intervention on executive functions in kindergartners: a proof-of-concept randomized controlled trial
Petra Haas
Gorden Sudeck
Augustin Kelava
Marcel Cattarius
Marie Meibohm
Johanna Schmid
Eirini Kistoglidou
Caterina Gawrilow
[J]. Pilot and Feasibility Studies, 8
[39] Implementation intentions for weight loss in college students with overweight and obesity: a proof-of-concept randomized controlled trial
Hayes, Jacqueline F.
Balantekin, Katherine N.
Graham, Andrea K.
Strube, Michael J.
Bickel, Warren K.
Wilfley, Denise E.
[J]. TRANSLATIONAL BEHAVIORAL MEDICINE, 2021, 11 (02) : 359 - 368
[40] Effect of exercise on cancer-associated cognitive dysfunction: A proof-of-concept randomized controlled trial.
Campbell, Kristin
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

← 1 2 3 4 5 →